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L. M. Downey,1 T. J. Keen,1 E. Roberts,1 D. C. Mansfield,2 M. Bamashmus,2
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We report a new locus for familial exudative vitreoretinopathy (FEVR), on chromosome 11p12-13 in a large
autosomal dominant pedigree. Statistically significant linkage was achieved across a 14-cM interval flanked by
markers GATA34E08 and D11S4102, with a maximum multipoint LOD score of 6.6 at D11S2010. FEVR is a
disease characterized by the failure of development of peripheral retinal blood vessels, and it is difficult to diagnose
clinically because of the wide spectrum of fundus abnormalities associated with it. The identification of a new locus
is important for genetic counseling and potentiates further studies aimed toward the identification of a gene with
an important role in angiogenesis within neuroepithelial tissues. Such a gene may also have a role in the genetic
predisposition to retinopathy of prematurity, a sporadic disorder with many clinical similarities to FEVR.
Familial exudative vitreoretinopathy (FEVR [MIM
133780]) is a bilateral disorder of the retinal vasculature,
characterized by an abrupt cessation of the growth of
peripheral retinal capillaries (Criswick and Schepens
1969; Miyakubo et al. 1984). Autosomal dominant in-
heritance was the first mode of segregation to be described
and is the most common form of this disease, although
recessive and X-linked pedigrees are also seen (Criswick
and Schepens 1969; Fullwood et al. 1993; De Crecchio
et al. 1998). The phenotype is variable; in severe cases,
the formation of fibrovascular vitreous membranes that
cause retinal traction may result in the displacement of
the macula, the presence of retinal folds, and/or the de-
tachment of the retina, any of which may cause a visual-
acuity decrease sufficient to result in legal blindness. Ret-
inal detachment may also occur as a result of vascular
exudation (Criswick and Schepens 1969; Benson 1995).
Patients with mild forms of the disease are asymptomatic,
and their only disease-related abnormality is an arc of
avascular retina in the extreme temporal periphery (Cris-
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wick and Schepens 1969; Ober et al. 1980). These indi-
viduals are difficult to diagnose with certainty. Fluorescein
angiography of the peripheral fundus is the definitive in-
vestigation; however, because it is an invasive procedure
that is not routinely performed, many individuals in pub-
lished pedigrees who are designated as normal may be
affected. Figures for penetrance are therefore speculative
but are thought to approach 100% when pedigrees are
tested by angiography (Ober et al. 1980).
Mutations have been identified in the gene for Norrie
disease (ND) (Xp11.4-p11.3) in several X-linked FEVR
pedigrees, and, as a consequence, the Norrie gene locus
is designated “EVR2” (Chen et al. 1993a; Shastry et al.
1995). This gene encodes a protein involved in neuronal
cell interactions during embryonic vascular development
(Meindl et al. 1992; Chen et al. 1993b). A single locus
(EVR1) has been identified for autosomal dominant dis-
ease, on 11q13-23 (Li et al. 1992; Muller et al. 1994).
We recently published exclusion of this locus in a large
autosomal dominant pedigree (Bamashmus et al. 2000),
proving locus heterogeneity within autosomal dominant
FEVR. In the present report, we describe the discov-
ery—in the same family—of a new FEVR locus, desig-
nated “EVR3,” on chromosome 11p12-13, ∼30 cM
from the known locus, EVR1.
The individuals studied here are members of a large
autosomal dominant pedigree originating in western
Scotland. A detailed description of their clinical pheno-
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Figure 1 Haplotypes for 31 members of the large pedigree with autosomal dominant FEVR. Blackened symbols indicate affected individ-
uals; blackened bars indicate the disease haplotype. The proximal crossover is seen in individual IV:5 and was detected by D11S4102 and other
markers more proximal to it. The distal crossover is in individual II:15 and was detected by marker GATA34E08 and another, more-distal
marker.
type has been published elsewhere (Bamashmus et al.
2000). Essentially, they show the usual variations in ex-
pression of the disease, with defective peripheral retinal
vascularization being the feature common to all affected
individuals. Retinal detachment was a frequent finding,
as was macular ectopia, with 150% of patients having
a Snellen acuity 6/60 in at least one eye. In addition,
small atrophic peripheral retinal holes were an unusually
prevalent feature of the phenotype in this pedigree. The
more severely affected family members usually presented
in childhood with poor vision, owing to macular trac-
tion. Slit-lamp biomicroscopy and indirect ophthalmos-
copy were performed on all individuals who were geno-
typed. Fluorescein angiography of the fundus was not
routinely performed but was used—whenever possible
and after informed consent had been obtained—to clar-
ify the diagnosis in mildly affected individuals.
Genomic DNA was extracted from peripheral blood
leukocytes obtained from 5–10 ml of venous blood, by
standard techniques. A cohort of 24 familymemberswas
screened for linkage across the whole genome, using a
panel of fluorescence-tagged microsatellite markers
spaced at 10-cM intervals. PCR reactions with these
markers were performed on an MWG Roboseq 4200
robot. Genotyping was then undertaken using an ABI
377 automated DNA sequencer (Applied Biosystems).
The products were identified and sized using GENE-
SCAN (version 2.0.2) and GENOTYPER (version 1.1.1)
software.
Alleles were initially screened by eye, to detectmarkers
suggesting linkage. For any such marker, data files pre-
pared on the LINKSYS (version 3.1) data-management
package were transferred to the LINKAGE (version 5.1)
suite of programs. In all analyses, we assumed autosomal
dominant inheritance with 90% penetrance. Allele fre-
quencies were estimated from the chromosomes of nor-
mal partners of affected family members, and, when pos-
sible, these estimates were compared with those availa-
ble from The Genome Database. This screen identified
several distinct chromosomal regions that appeared to
780 Am. J. Hum. Genet. 68:778–781, 2001
Figure 2 Chromosome 11 ideogram showing the approximate
positions of genes implicated in various retinal phenotypes, mapped
according to their distance from the 11p telomere. Distances are com-
posites derived from the databases of Retnet, OMIM, and the Centre
for Medical Genetics, Marshfield Medical Research Foundation. AA
p locus for atrophia areata; BBS1p locus for Bardet-Biedl syndrome
locus; EVR1 p locus for autosomal dominant familial exudative vit-
reoretinopathy locus; EVR3 p locus for the new locus described in
the present article; MYO7A p locus for Usher syndrome 1B; ROM1
p gene involved in digenic and, possibly, in dominant retinitis pig-
mentosa; USH1C p locus for Usher syndrome 1C; and VNR1 p
locus for autosomal dominant inflammatory vitreoretinopathy.
Table 1







LOD SCORE AT va p
.0 .01 .05 .1 .2 .3 .4
D11S1981 21.5 4.70 .83 .44 .84 .93 .70 .35
ATA34E08 33.0 1.59 1.54 1.91 1.81 1.33 .78 .31
D11S2364 33.6 4.18 4.10 3.77 3.34 2.42 1.46 .58
D11S2001 37.6 5.18 5.10 4.77 4.29 3.21 2.03 .85
D11S2010 40.9 6.43 6.32 5.89 5.32 4.05 2.62 1.13
D11S4965 41.0 1.56 .35 1.46 1.68 1.47 1.00 .48
D11S1392 43.2 3.27 3.25 3.11 2.85 2.17 1.38 .61
D11S935 45.9 1.99 1.95 1.80 1.60 1.21 .81 .40
D11S4102 47.6 .87 4.37 4.71 4.49 3.61 2.43 1.13
D11S4966 48.7 3.16 3.10 2.86 2.53 1.84 1.15 .53
D11S1911 50.9 3.42 3.38 3.21 2.92 2.19 1.36 .57
D11S905 52.0 .74 .77 .84 .85 .73 .51 .25
D11S1785 53.9 5.94 .58 1.75 2.01 1.81 1.27 .62
D11S903 54.7 3.81 .96 .13 .21 .37 .25 .05
a Values were calculated using MLINK. Maximum LOD scores for
each marker are underlined.
cosegregate with FEVR. One of the regions contained
marker D11S1392, which gave a LOD score of 1.99 in
this panel of patients. When the linkage panel was ex-
tended to include seven additional family members, the
LOD score with this marker increased to 3.27, with no
recombination. By genotyping this extended panel with
further nearby markers, we obtained a maximum two-
point LOD score of 6.43 at D11S2010, again with no
recombination, using the programMLINK. Three-point
linkage analysis, using the LINKMAP program with
both these markers, gives a maximum LOD score of 6.6
at D11S2010, proving beyond reasonable doubt the ex-
istence, at chromosome 11p12-13, of a second locus for
autosomal dominant FEVR.
Haplotype analysis with markers in this region (fig. 1)
places the involved gene within a 14-cM interval that is
defined by markers GATA34E08 (distal) and D11S4102
(proximal). This locus is distinct from those of an as-
sortment of other inherited retinal diseases that map on
chromosome 11, including the initial autosomal FEVR
locus EVR1 (see fig. 2). One clinically normal individual
(V:5) has inherited the affected haplotype. This individual
has not undergone fluorescein angiography of the pe-
ripheral fundus, because of the practical difficulties of
performing such a procedure on a child. Therefore, this
result may have occurred because of the variability in
expression of the disease—exemplified by the mild phe-
notype in this patient—rather than because of a discrep-
ancy in genetic analysis. Two-point LOD scores for mark-
ers typed across the region are shown in table 1.
The region between markers GATA34E08 and
D11S4102 contains ∼100 expressed-sequence tags, sev-
eral of which show retinal expression, togetherwith14
characterized genes (GeneMap’98). Candidate genes for
FEVR are expected to have a role in peripheral retinal
vascular development. In particular, proteins involved in
retinal angiogenesis, rather than vasculogenesis, are im-
plicated. Proteins involved in angiogenesis are implicated
because central retinal vessels are thought to arise as a
result of vasculogenesis, whereas the extreme retinal pe-
riphery, which is defective in FEVR, is formed by an-
giogenesis and vascular remodeling (Hughes et al. 2000).
Genes that have been characterized in this region and
that may be relevant to FEVR include the gene for brain-
derived neurotrophic factor, PAX6 (a homeobox gene
and an important coordinator of ocular development),
and the genes for basic transcription factor 3, rhombotin
2, and solute-carrier family 1, member 2 (SLC1A2).
The molecular defect that underlies FEVR is unclear.
Failure of peripheral retinal vascularization is the com-
mon feature in an otherwise variable phenotype, lead-
ing to speculation that vessel development is defective.
Of significance is the existence of the sporadic disorder
retinopathy of prematurity (ROP), which is an excellent
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phenocopy for FEVR (Benson 1995). Affected pre-
mature infants invariably show poor peripheral retinal
vascularization, which, in a small percentage, may lead
to fibrovascular proliferation and tractional retinal de-
tachment, producing a clinical appearance identical to
that seen in FEVR. Several environmental factors, of
which exposure to high oxygen tensions is historically
the most significant, have a role in determining which
neonates are at risk. However, extreme prematurity and
low birth weight are also significant risk factors for the
disease (Gibson 1989). As a consequence, the incidence
of ROP is increasing, despite careful monitoring of ox-
ygen therapy, as more premature infants survive. Evi-
dence of a genetic basis of ROP comes from an observed
racial bias in disease incidence (Saunders et al. 1997),
together with the recent tentative demonstration of mu-
tations in the ND gene in a small cohort of infants with
severe ROP (Shastry et al. 1997).
The identification of the other genes that are defective
in FEVR is therefore important, because these may con-
tain polymorphisms that produce a genetic predisposi-
tion to severe ROP. Characterization of such genes will
also provide valuable information regarding the molec-
ular pathways involved in angiogenesis within neuro-
epithelial tissues.
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